HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Data Supplements All Versions of this Article: clinchem.2005.049908v1 51/10/1796    most recent Submit an electronic Letter to the Editor about this paper Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (16) Citing Articles via Google Scholar Google Scholar Articles by Amacher, D. E. Articles by Townsend, R. R. Search for Related Content PubMed PubMed Citation Articles by Amacher, D. E. Articles by Townsend, R. R. Related Collections Proteomics and Protein Markers

Use of Proteomic Methods to Identify Serum Biomarkers Associated with Rat Liver Toxicity or Hypertrophy

¹ Molecular & Investigative Toxicology, World Wide Safety Sciences, Groton, CT.
² World Wide Safety Sciences, Ann Arbor, MI.
³ Bioinformatics, Nestle Research Center, Lausanne, Switzerland.
⁴ Washington University School of Medicine, Department of Internal Medicine, St. Louis, MO.

^aAddress correspondence to this author at: Molecular & Investigative Toxicology, World Wide Safety Sciences, Mailstop 8274-1227, Pfizer Inc., Groton, CT 06340. Fax 860-441-5499; e-mail david.e.amacher{at}pfizer.com.

Background: Our objectives were to identify serum marker proteins in rats that might serve as sensitive indicators of hepatomegaly, hepatocellular necrosis, or hepatobiliary injury and to use them to analyze data from a collaborative proteomics project.

Methods: In each of 4 studies comprising the collaborative project, rats were given 1 of 4 compounds that target the liver through different mechanisms. Sera and liver samples were collected by terminal bleeds at 1 of 3 postdose time points. Sera were depleted of major secretory proteins and then separated into protein features by 2-dimensional gel electrophoresis (2DGE). Liver specimens were also processed and subjected to 2DGE. Protein spots that significantly increased or decreased in quantity after drug treatment were recovered, digested, analyzed by mass spectroscopy, and compared with available databases for identification. Criteria for further consideration were (a) temporal expression (i.e., increase or decrease at early, fulminant, or recovery periods), (b) known biological function, (c) probable hepatic origin, and (d) any previous association with toxicity in published studies. Markers that changed significantly at the early time point were important because of their potential sensitivity for signaling minimal damage.

Results: Vitamin D–binding protein, paraoxonase, cellular retinol-binding protein, malate dehydrogenase, F-protein, and purine nucleoside phosphorylase were identified as empirically confirmed serum markers for hepatic effects in drug-treated rats.

Conclusion: Proteomics can be applied for the identification and confirmation of peripheral biomarkers for altered liver function after toxicant exposure.

The following articles in journals at HighWire Press have cited this article:

				B. Gangadharan, R. Antrobus, R. A. Dwek, and N. Zitzmann Novel Serum Biomarker Candidates for Liver Fibrosis in Hepatitis C Patients Clin. Chem., October 1, 2007; 53(10): 1792 - 1799. [Abstract] [Full Text] [PDF]

				B. A. Merrick, M. E. Bruno, J. H. Madenspacher, B. A. Wetmore, J. Foley, R. Pieper, M. Zhao, A. J. Makusky, A. M. McGrath, J. X. Zhou, et al. Alterations in the Rat Serum Proteome during Liver Injury from Acetaminophen Exposure J. Pharmacol. Exp. Ther., August 1, 2006; 318(2): 792 - 802. [Abstract] [Full Text] [PDF]